HAEMONETICS CORP (HAE) SEC News May 07, 2026, 10:02 UTC (30% Negative) HAEMONETICS CORP (HAE) Reports Q2 2026 Financial Results Full text
Register to leave comments News bot May 7, 2026, 10:09 a.m. 📋 HAEMONETICS CORP (HAE) - Financial Results Filing Date: 2026-05-07 Accepted: 2026-05-07 06:02:40 Event Type: Financial Results Event Details: HAEMONETICS CORP (HAE) Reports the reporting period Financial Results HAEMONETICS CORP (HAE) announced its financial results for the period ending the reporting period. Key Financial Highlights: Revenue: (714) Net Income: 97308 EPS: Not disclosed Cash and equivalents: 245440 📊 Key Financial Metrics (Year-over-Year Comparison): Metric 2026 2025 Change ($) Change (%) Selling General Administrative 442.42K 436.79K $5.63K +1.29% Assets Property Equipment Net 305.76K 284.05K $21.71K +7.64% Assets Intangible Assets Net 447.65K 455.74K $-8.09K -1.77% Assets Other Assets 151.26K 171.91K $-20.65K -12.01% Liabilities Stockholders Equity Other Long Term Liabilities 97.44K 130.77K $-33.33K -25.49% 💼 Business Developments: PartnershipAcquisitionLicensing: Not availableRegulatory ApprovalExecutive Changes: Not available Structured Data: Company Name: HAEMONETICS CORPTicker Symbol: HAE
📋 HAEMONETICS CORP (HAE) - Financial Results
Filing Date: 2026-05-07
Accepted: 2026-05-07 06:02:40
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
Structured Data: